IL6 and systemic sclerosis: In order to understand IL-6 modulated cellular and molecular signals dysregulated in SSc patient skin, we performed unbiased RNAseq analyses of skin punch biopsies collected as part of a large phase 3 study of TCZ in SSc, and identified a gene signature attributable to plasma cells (PCs) that is elevated in SSc skin and correlated with disease progression.